Shengping Li, M.D., Ph. D. Dept. of Hepatobiliary Oncology, Cancer Center, Zhongshan University 
  
Address:
    651 Dongfeng Road, East
   Guangzhou 510060
    P.R.China
     Tel: 86-020-87765368-5217
      E-mail: shengpingli@hotmail.com;
                 spli@umich.edu
 
Education:
Sep. 1995---Jul. 1998: Ph.D., Medical Science, Sun Yat-sen University of Medical Sciences Molecular mechanism of tumor invasion and metastases
Sep.1998---Jul. 1991: M.S., Medicine, Sun Yat-sen University of Medical Sciences Prevention of liver dysfunction following ischemia.
Sep. 1981---Jul. 1986 M.D., Medicine, School of Medicine, Nanhua University ( Hengyang Medical college)
Jan. 2001---present Postdoctoral Research fellow, University of Michigan, USA
   
Experiences:
Jan. 2001---present Associate professor. Dept. of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University of Medical Sciences, China
Jul. 1998---Dec. 2000 Attending Doctor, Dept. of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University of Medical Sciences.
General practice of surgery in primary liver cancer, transcatheter arterial embolization(TAE).Basic research in molecular mechanisms of tumor metastasis
Jul. 1991---Aug. 1995 Resident, Attending Doctor, Dept. of General Surgery, Fist Municipal People’s of Guangzhou
Mar. 1994---Jun. 1994 Visiting Scholar, Dept. of Gastrointestinal Surgery, University of Southern California, University Hospital, Los Angeles, USA Laparoscopy.
  
Research Funding:
2000 Multidisciplinary therapy of hepatocellular carcinoma. P.I. Funded by Guangdong Science and Technology committee.
1998 The molecular mechanism of angiogenesis after transcatheter arterial embolization in hepatocellular carcinoma.
P.I. Funded by Health office of Guangdong.
1996 The molecular mechanism of tumor metastasis of colorectal carcinoma. PI. Funded by Board of Health of Guangzhou
   
Awards:
  Scholarship in Medicine for Excellent Candidate of Doctoral Degree;
International Health Exchange Center, Ministry of Health, China, 1998.
 
aboratory Skills:
Animal tumor models, cell culture, basic molecular biology techniques including PCR, Northern Blot, Western Blot, Southern Blot, molecular cloning, etc.
     
Publications:
  1. Li SP, Wang HY, Li, JQ, et al: Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J Hepatology,2001,34(6):840-9
2.Li SP, Wang HY, Zhang CQ, et al. Loss of heterozygosity in hepatocellular carcinoma. Report results in 65 cases. Chin J med, 2000, 80(8): 577
3.Li SP, Zhang CQ, Li JQ, et al. Intrahepatic subclinical metastases and its clinicopathological significance in hepatocellular carcinoma. Chin Clini Oncol (in press)
4.Li SP, Li JQ, Zhang CQ, et al. Comprehensive analyses of loss of heterozygosity in hepatocellular carcinoma in Southern China. J Gastroen Hepatol, 2000,15(Suppl): 1143
5. Li SP, Li JQ, Zhang CQ, et al. Deletion of chromosome 1 and its clinical significance in hepatocellular carcinoma. Chin J Cancer, 2000,19(7): 674
6. Lin XJ, Li SP, Li JQ, et al. Implication of serum vascular endothelial growth factor and hepatocyte growth factor levels in intrahepatic metastasis of hepatocellular carcinoma. J Gastroen Hepatol, 2000, 15(Suppl):1164
 7. Guo RP, Li GH, Li SP, et al. Treatment relapse by resection in primary liver cancer. Chin J Hepatobil Surg, 2000, 6(6): 254
 8.Guo RP, Chen MS, Lin XJ, Li SP, et al. Combinig extraction and chemoembolization in treatment of the primary liver cancer with port vein invasion. Chin J Hepatobili Surg, 2000; 6(5): 374
9.Li SP, Li JQ. Angiogenesis and tumor metastasis. Guowai Medicine (tumor section) 1999; 26 (suppl):168
 10.Chen MS, Guo RP, Li SP, et al. Combinative procedure for treatment of intrahepatic recurrence in primary liver cancer. Practice J Oncol, 1999; 139(4): 275
11.Li SP, Wang JF, Liu JH, et al. Expression of nm23-H1 associated with hepatic metastasis and prognosis in colorectal carcinoma. Chin J Cancer, 1998; 17(1): 38
 12.Li SP, Zhu ZY, Wang HY, et al. Correlative study LOH of nm23-H1 gene and lymph node metastasis in colorectal carcinoma. Acad J SUMS, 1998; 19(2): 115
13.Li SP,Wang JF, Zhang CQ, et al. Relationship between expression of CD44v6 gene and prognosis in colorectal carcinoma. Chin J Exp Surg, 1998; 15(4): 294
14.Li SP, Wang JF. Adhesive molecule CD44 and colorectal carcinoma. Guowai Medicine (molecular biology section), 1998, 20:203
15.Tan WM, Li SP, Liu HJ,et al. Comparative study on the characteristic of gastric carcinoma between young and elder patients. Chin J Gastroen Surg, 1998; 1:115
16.Li SP, Wang JF, Zhang CQ, et al. The relation between expression of a CD44 variant containing exon 6 and metastasis in colorectal cancer. Chin J Gene Surg, 1997; 6(6): 337
17.Li SP, Liu JH, Tai WM, et al. Changes of activity of NK and ADCC and expression of sIL-2R pre- and post-operation. Medicine of Guangdong, 1997; 18(3): 190
18.Tan WM, Li SP, Liu JH, et al. Surgical treatment of duodenal diverticulum. Medicine of Guangdong, 1997; 18(5): 304
19.Li SP, Liu JH, Tan WM, et al. Treatment of duodenal fistula after gastrectomy. Practice of Medicine, 1996;12(3):160
20.Li SP, Tan WM, Liu JH, et al. Intestinal carcinoma : reported 22 cases. Medicine of Guangdong, 1995; 16(11): 737.
21.Liao J, Chen F, Deng QY, Li SP, et al. Dynamic inspect of alteration of two immunological parameters perioperation in colorectal carcinoma. J Immunol of Shanghai, 1995; 15(5): 294
22.Li SP, Chao XH, Huang JF, et al. Surgical treatment of proximal cholangiocarcinoma: reported 106 cases. Medicine of Guangdong, 1993, 14(6): 307
 23.Li SP, Chao XH, Liu JF, et al. Study of relation between differentiation of tumor cells and prognosis. Abdominal Surg, 1993, 8(2):64
24.Huang JF, Li SP, Chao XH, et al. Cholecyst and right hepatic duct anastomosis as a palliative procedure to relieve jaundice in unresectable proximal cholangiocarcinoma. Chin J Surg.1990, 28(9): 527